Proposed
Bill · 119th Congress · S 4885
Shandra Eisenga Human Cell and Tissue Product Safety Act
Refreshed 3 h ago
Introduced 2026-06-24Topic: health care · public healthSummary
AI-generated summary, report an errorThis bill would require the Secretary of Health and Human Services to support educational materials for health care professionals about organ, tissue, and eye donation and donor screening tests. It would create civil penalties for people who violate certain federal rules on human cell and tissue products, up to $20,000 per violation plus the retail value of the products, with a $10 million cap per proceeding. The Food and Drug Administration would have to publish information online about its Tissue Reference Group, registrations and inspections of tissue establishments, and response times, and hold workshops for stakeholders. The Secretary would also open a public comment docket on modernizing these rules and send recommendations to Congress.
Sponsors
- Gary C. Peters Democrat sponsor
- 1 cosponsors
Action history
| Date | Chamber | Action | Status effect |
|---|---|---|---|
| 2026-06-24 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | refer |
| 2026-06-24 | Introduced in Senate | introduce |